Abstract : Intracholecystic papillary-tubular neoplasm ICPN has recently been proposed as a new disease concept in the classi cation of gallbladder tumors. ICPN is de ned as a papillary or polypoid glandular neoplasm forming a localized, noninvasive mass ≥ 1 cm in the gallbladder. We analyzed the clinicopathological characteristics of ICPN. Resected gallbladder cancer specimens from 57 patients were classi ed as ICPN or non-ICPN and clinicopathological characteristics were compared. ICPN cell characteristics were also analyzed using immunostaining and genetic analysis. Twenty-three cases were classi ed as ICPN and 34 as non-ICPN. In the ICPN and non-ICPN groups, mean ages were 69 and 74 years, male:female ratios were 14:9 and 15:19, mean tumor diameters were 2.8 and 2.6 cm, invasion depths were Tis T1/T2 T3 in 14/9 cases and 13/21 cases, lymph node metastases were present in 6 and 43 , distant metastases in 0 and 6 and 3-year survival rates were 91 and 52 , respectively. Signi cant intergroup differences were seen in lymph node metastases and the 3-year survival rate. ICPN cell lineage was biliary-type in 13 cases, gastric-type in 8 and intestinal-type in 2. This proportion differs from that of pancreatic intraductal papillary mucinous neoplasm IPMN , in which gastric-and intestinal-type are more common. KRAS gene mutations were only seen in 1 of 13 ICPN cases. ICPN is frequently seen in gallbladder cancer, showing similar pathology to pancreatic IPMN, which is considered to have a relatively good prognosis among pancreatic cancers. However, ICPN cell characteristics are not necessarily identical to those of pancreatic IPMN.
Adsay et al 1 recently proposed intracholecystic papillary-tubular neoplasm ICPN as a new disease concept in the classification of gallbladder tumors. ICPN is termed as an intracystic papillary neoplasm in the 4th edition of the World Health Organization Classification of Tumors of the Digestive System published in 2010 3 . ICPN resembles pancreatic intraductal papillary mucinous neoplasm IPMN , which commonly develops in the duct of pancreatobiliary system 4 5 , as well as in intraductal papillary neoplasms of the bile duct 6 and intra-ampullary papillary-tubular neoplasms 7 . ICPN is primarily defined as a papillary or polypoid glandular neoplasm forming a localized, non-invasive mass ≥ 1 cm in the gallbladder 1 3 . ICPN could provide a useful concept for decisions on treatment strategies for gallbladder cancer if the pathological features resemble those of pancreatic IPMN, which is considered a relatively indolent form of pancreatic cancer. We compared the clinicopathological features of ICPN and non-ICPN cases using specimens from resected gallbladder cancers to determine whether ICPN can be considered the gallbladder counterpart of pancreatic IPMN. We also analyzed ICPN cell characteristics and compared these with pancreatic IPMN.
Subjects and Methods
The study included 57 patients with gallbladder cancers which were surgically resected at the authors hospitals Showa University Hospital and Showa University Fujigaoka Hospital between 1998 and 2012. All patients gave their informed consent and personal information was hidden during the investigation of the medical records.
In accordance with the proposal by Adsay et al 1 , tumors were considered to be ICPN if all three of the following components were present : 1 a non-invasive glandular neoplasm growing in the gallbladder mucosa ; 2 formation of localized papillary or polypoid protruded lesions clearly distinguishable from the surrounding mucosa Fig. 1 ; and 3 diameter of at least 1 cm.
Cases showing all three components were included in the ICPN group, and all other cases were included in the non-ICPN group. As with the criteria for intraductal papillary neoplasms of the bile duct and intra-ampullary papillary-tubular neoplasms, the presence of excess mucus production was not considered relevant.
Clinicopathological analysis
We compared and analyzed the mean age, male:female ratio, mean tumor diameter, invasion depth, lymph node metastasis-positive rate, distant metastasis-positive rate and postoperative prognosis of the ICPN and non-ICPN groups. During the postoperative observation period, which ranged from 45 days to 4079 days, 6 patients died ICPN group, n 5 ; non-ICPN group, n 1 . All 6 deaths were clearly attributable to another disease myocardial infarction, pneumonia, etc. , and were therefore excluded from the analysis of prognosis. The statistical tests used were the t-test, the chi-square test and the log-rank test for the Kaplan-Meier survival curve. Values of P 0.05 were considered significant.
Analysis of ICPN cell characteristics
Cell types in the ICPN group were identified using histopathological and immunohistochemical methods.
1 Histomorphological analysis All ICPN cases were histomorphologically classified as biliary, intestinal or gastric through observation of hematoxylin and eosin-stained specimens using light microscopy. Biliary-type cells are cuboidal or short-columnar epithelial cells with oval nuclei and poor mucinous cytoplasm, resembling proper biliary tract epithelium Fig. 2a , while intestinal-type cells resemble those of colon adenoma or colon carcinoma, and are tall-columnar epithelial cells with spindle, pseudostratified nuclei and eosinophilic or dark cytoplasm Fig. 2b . The presence of goblet cells and Paneth cells is also considered indicative of intestinal lineage. Gastric-type cells consist of tall-columnar epithelium with mucinous cytoplasm resembling foveolar epithelium, and/or small-tubular epithelium resembling pyloric glands Fig. 2c . If these characteristics were seen to overlap, cell characteristics were determined by agreement between the observers MI, NO, and TT , taking into account the dominant features and degree of atypism.
2 Immunohistochemical analysis All specimens from the ICPN group underwent immunohistochemical staining. Thin sections 3 µm were prepared for immunostaining using one or two formalin-fixed, paraffin-embedded tissue sections including the center of the tumor from each patient. Staining was performed using the avidin-biotin complex detection method with a BenchMark automated immunostainer 
KRAS Testing
The presence of mutations in codons 12 and 13 of the KRAS gene was analyzed using the ARMS-Scorpion method. Thirteen cases from Showa University Hospital were selected from among the ICPN cases. A 10-µm thick section was prepared from a formalin-fixed, paraffinembedded tissue section including the center of the tumor from each selected case. Testing was performed by a clinical testing company SRL, Tokyo, Japan 8 . Briefly, the assay was designed to detect a wild-type control and the seven most common KRAS exon 2 mutations, ie, Gly12Ala, Gly12Asp, Gly12Arg, Gly12Cys, Gly12Ser, Gly12Val, and Gly13Asp. Real-time polymerase chain reaction 7900HT, Life Technologies, Tokyo, Japan was performed using 15 20 ng of genomic DNA for each of the eight mixtures. Data regarding each mutation were interpreted according to the kit manual after curve analysis and calculation of cycle threshold Ct values sample mutation assay Ct minus sample control assay Ct .
Results
Of the 57 cases of gallbladder cancer, 23 40 were categorized as ICPN and the remaining 34 60
were categorized as non-ICPN Clinicopathological analysis Table 1 Comparison of the ICPN and non-ICPN groups revealed no significant differences in mean age 69 and 74 years, respectively or male:female ratio 14:9 and 15:19, respectively . Mean tumor diameters were also similar, at 2.8 cm and 2.6 cm, for ICPN and non-ICPN, respectively. When tumor depth was classified as non-invasive tumor Tis , tumor invading mucosa T1a , solid tumor invading the muscle layer T1b , tumor invading the subserosa T2 , or tumor invading the serosal surface or adjacent organs T3 , the breakdown of the ICPN group was 14 cases 61 in the Tis T1 group, 7 cases in the T2 group and 2 cases in the T3 group. In comparison, in the non-ICPN group, the figures were 13 38 , 14 and 7 cases, respectively. No significant differences were apparent, but more cases in the ICPN group tended to show lessinvasive tumors. The lymph node metastasis-positive rate was 6 in the ICPN group, which was significantly lower than the 43 in the non-ICPN group. Distant metastasis was not seen in the ICPN group. The postoperative 3-year survival rate was 91 in the ICPN group which was significantly higher than the non-ICPN group 52 ; P 0.03 . The 5-year survival rate and Kaplan-Meier curve Fig. 3 also showed better trends for the ICPN group, although the differences were not significant. When looking at the 3-year survival rate of cases with the same invasion depth, the ICPN group tended to show a higher 3-year survival rate for T2 T3, although the number of cases was small and the difference was not significant Table 2 . Fig. 4 . These results were consistent with the histomorphological features. The predominant Fig. 3 . Kaplan-Meier survival curve ICPN group shows higher survival rate than non-ICPN group, but no significant difference is detected between two groups in the log-rank test.
Analysis of ICPN cell characteristics
growth patterns were papillary in 11 cases and tubular in 2 cases with biliary-type cells, papillary in 3 cases and tubular in 5 cases with gastric-type cells, and papillary in both cases with intestinal-type cell characteristics.
KRAS Testing
A KRAS gene mutation was only seen in one of the 13 ICPN specimens tested an intestinal-type ICPN . The amino acid mutation type was G12V.
Discussion

ICPN was found in 40
23 of 57 of the resected gallbladder cancer specimens examined, and of the 44 cases considered to be invasive cancer, ICPN was seen in 14 32 . In Japanese papers on this subject, Akashi et al 9 studied material from 30 resected gallbladder States may be due to differences in early detection rates, indications for surgery or ethnic factors. The possibility of ethnic differences is interesting, particularly when considering the incidence of gallbladder cancer, which has a high incidence in Eastern Europe, Chile and Japan 3 .
We found several significant results when comparing clinicopathological factors in the ICPN and non-ICPN groups. Although the number of cases was small and no significant differences were detected, the ICPN group tended to include many cases of low invasive depth, including 14 of 23 cases 61
of Tis T1, compared to 13 of 34 cases 38 in the non-ICPN group. This trend was complemented by the significantly lower lymph node metastasis rate and higher 3-year survival rate in the ICPN group compared to the non-ICPN group. Adsay et al 1 also
reported a large number of cases with low tumor depth in the ICPN group, with 32 of cases at T1 in that group, compared to 9 in the non-ICPN group. One of the reasons for this difference could be that protruding ICPN lesions are highly likely to be detected by clinical imaging and consequently resected at a relatively early stage. However, another possibility is that invasiveness is an unlikely complication with ICPN, and invasion may progress slowly even when it occurs. The finding that ICPN had a high 3-year survival rate in this study at each category of tumor depth was noteworthy, although unfortunately the number of cases was small and no significant difference was detected. In cancers which had advanced to at least T2 invasion of subserosa , Kanda et al 10 reported that the 5-year survival rate was 50 for papillary tumors, compared to 34 for invasive papillary tumors. This result may suggest that ICPN could be considered a biliary counterpart of pancreatic IPMN, which is considered a relatively indolent form of pancreatic cancer 4 5 . This should be clarified by the accumulation of further cases. The possibility that ICPN is the biliary counterpart of pancreatic IPMN is also supported by the fact that ICPN components include a diverse histomorphological growth pattern ranging from papillary to tubular, together with diverse cell characteristics, resembling those of pancreatic IPMN. Nevertheless, there are several differences between ICPN and pancreatic IPMN. We found ICPN cell characteristics to be biliary-type in 13 cases, gastric-type in 8, and intestinaltype in 2, while Adsay et al 1 reported a similar proportion among ICPN cases biliary-type, 69 ;
gastric-type, 44 ; intestinal-type, 10 . In contrast, pancreatic IPMNs mainly consist of cells of the gastric-type or villous intestinal-type 4 5 . This difference may be due to anatomical differences or differences in the nature of the preneoplastic lesions, but another factor could be that the presence of excess mucus production is not essential in the definition of ICPN. This is similar for biliary intraductal papillary neoplasms and papillary-tubular neoplasms of the ampulla, where biliary-type and tubular intestinal-type cells are more frequent 6 7 , and consequently the patterns of cell characteristics in these tumors also differ from pancreatic IPMN. Additionally, the differences in cell characteristics might also be reflected in the fact that only 1 of 13 ICPN cases in our study had a KRAS mutation, whereas pancreatic IPMN has a high KRAS mutation rate of 30 80 3 11 12 .
Conclusions
ICPN is frequently seen in gallbladder cancer, and could be regarded, clinicopathologically, as the gallbladder equivalent of pancreatic IPMN. However, the cell characteristics of these two diseases are not necessarily identical.
